Topical Finasteride in the Treatment of Idiopathic Hirsutism

This study has been completed.

First Received: November 26, 2007 No Changes Posted

Sponsor:	Iran University of Medical Sciences
Collaborator:	Firuzgar hospital affiliated to Iran University of Medical Sciences
Information provided by:	Iran University of Medical Sciences
ClinicalTrials.gov Identifier:	NCT00564252

Purpose

the purpose of this study is to evaluate the efficacy of topical Finasteride in the treatment of idiopathic hirsutism

Condition	Intervention
Idiopathic Hirsutism	Drug: topical finasteride

Study Type:	Interventional
Study Design:	Treatment, Single Blind (Subject), Single Group Assignment
Official Title:	The Efficacy of Topical Finasteride in the Treatment of Idiopathic Hirsutism

Resource links provided by NLM:

Drug Information available for: Finasteride

Further study details as provided by Iran University of Medical Sciences:

Primary Outcome Measures:

the efficacy of topical finasteride was determined by comparison of Ferriman-Gallwey score before and after medication [ Time Frame: 6 months ]

Secondary Outcome Measures:

the efficacy of topical finasteride was determined by comparison of mean hair thickness before and after medication [ Time Frame: 6 months ]

Intervention Details:

0.2%topical(cream)finasteride twice a day for six months

Eligibility

Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Idiopathic hirsutism which is defined as normal levels of androgens and normal ovulation
Normal serum prolactin

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00564252

Sponsors and Collaborators

Iran University of Medical Sciences

Firuzgar hospital affiliated to Iran University of Medical Sciences

Investigators

Study Director:

iraj heydari, professor assistant

endocrine and metabolism centre of Iran University of Medical Sciences

More Information

No publications provided

Study ID Numbers:	84-5-6886, IUMS127
Study First Received:	November 26, 2007
Last Updated:	November 26, 2007
ClinicalTrials.gov Identifier:	NCT00564252 History of Changes
Health Authority:	Iran: Ethics Committee

Additional relevant MeSH terms:

Finasteride
Hair Diseases
Signs and Symptoms
Hirsutism
Molecular Mechanisms of Pharmacological Action

Skin Diseases
Enzyme Inhibitors
Virilism
Pharmacologic Actions

ClinicalTrials.gov processed this record on February 08, 2010